secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenon Pharmaceuticals Inc. (XENE)
CIK:        0001582313
Form:       8-K
Filed at:   2025-03-17T23:59:59+00:00
Accession:  0000950170-25-040381
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xenon Pharmaceuticals sets 2025 annual meeting for June 4, record date April 7
------------------------------------------------------------------------------

- Annual meeting of shareholders scheduled for June 4, 2025.
- Record date for notice and voting is April 7, 2025.
- Common shares are the only securities entitled to vote.
- Issuer will use notice-and-access for both registered and non-registered investors.
- Issuer will pay for distribution of materials to objecting beneficial owners.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582313/000095017025040381/0000950170-25-040381-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582313/000095017025040381/xene-20250314.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-040381

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer